BRPI0419105A - usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno - Google Patents

usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno

Info

Publication number
BRPI0419105A
BRPI0419105A BRPI0419105-6A BRPI0419105A BRPI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A BR PI0419105 A BRPI0419105 A BR PI0419105A
Authority
BR
Brazil
Prior art keywords
karyophyllenes
inflammatory
compositions
composition
karyophyllene
Prior art date
Application number
BRPI0419105-6A
Other languages
English (en)
Inventor
Luiz F Pianowski
Joao B Calixto
Dagoberto De C Brandao
Original Assignee
Ache Lab Farmaceuticos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ache Lab Farmaceuticos Sa filed Critical Ache Lab Farmaceuticos Sa
Publication of BRPI0419105B1 publication Critical patent/BRPI0419105B1/pt
Publication of BRPI0419105A publication Critical patent/BRPI0419105A/pt
Publication of BRPI0419105B8 publication Critical patent/BRPI0419105B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USOS DE CARIOFILENOS OU COMPOSIçõES QUE COMPREENDEM CARIOFILENOS, MéTODO DE TRATAMENTO DE CONDIçõES INFLAMATóRIAS E DORES INFLAMATóRIAS, MéTODO DE INIBIçãO E COMPOSIçãO QUE COMPREENDE CARIOFILENO A presente invenção refere-se ao uso de cariofilenos relativos a medicamentos e ao tratamento de condições corpóreas de inflamações e dores inflamatórias.
BRPI0419105-6A 2004-10-01 2004-10-01 usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno BRPI0419105A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2004/000189 WO2006037194A1 (en) 2004-10-01 2004-10-01 Use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain

Publications (3)

Publication Number Publication Date
BRPI0419105B1 BRPI0419105B1 (pt) 2006-04-13
BRPI0419105A true BRPI0419105A (pt) 2007-12-11
BRPI0419105B8 BRPI0419105B8 (pt) 2021-05-25

Family

ID=36142256

Family Applications (2)

Application Number Title Priority Date Filing Date
BR122016029094-8A BR122016029094B1 (pt) 2004-10-01 2004-10-01 Composição farmacêutica anti-inflamatória
BRPI0419105-6A BRPI0419105A (pt) 2004-10-01 2004-10-01 usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR122016029094-8A BR122016029094B1 (pt) 2004-10-01 2004-10-01 Composição farmacêutica anti-inflamatória

Country Status (9)

Country Link
US (1) US20080280996A1 (pt)
EP (1) EP1809268B1 (pt)
JP (1) JP2008514649A (pt)
AR (1) AR048806A1 (pt)
AT (1) ATE518531T1 (pt)
BR (2) BR122016029094B1 (pt)
CA (1) CA2577219A1 (pt)
MX (1) MX2007002116A (pt)
WO (1) WO2006037194A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066305A1 (en) * 2005-12-09 2007-06-14 Zelpy 2549 (Pty) Limited Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
JP2012077002A (ja) * 2010-09-30 2012-04-19 Oita Univ ＡＴＬ及びＨＴＬＶ−１関連炎症疾患をターゲットとしたＮＦ−κＢ亢進抑制剤及びその用途
WO2013140342A1 (en) * 2012-03-19 2013-09-26 Ariel-University Research And Development Company, Ltd. Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists
KR101477552B1 (ko) * 2012-12-07 2014-12-30 세명대학교 산학협력단 유제놀 유도체를 함유하는 아토피성 피부염의 치료용 약제학적 조성물 및 그 제조방법
CN107530318A (zh) 2015-03-02 2018-01-02 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US10039740B2 (en) * 2015-10-23 2018-08-07 Primus Pharmaceuticals, Inc. Therapeutic combinations of sesquiterpenes and flavonoids
US10456365B2 (en) * 2016-03-25 2019-10-29 Primus Pharmaceuticals, Inc. Methods and formulations for supporting and promoting bone health
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
WO2018033891A1 (en) * 2016-08-19 2018-02-22 Aurea Biolabs Private Limited An anti-inflammatory composition for the treatment of acute joint inflammation and a process for preparation thereof
KR102043893B1 (ko) * 2018-01-05 2019-11-12 인제대학교 산학협력단 알파-휴물렌(alpha-Humulene)을 유효성분으로 포함하는 소화기계 점막 관련 질환 예방 또는 치료용 조성물
KR102040810B1 (ko) * 2018-01-31 2019-11-05 인제대학교 산학협력단 알파-휴물렌을 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987008A (en) 1971-12-17 1976-10-19 Celanese Corporation Flame retardant polyester
NL9100688A (nl) 1991-04-19 1992-11-16 Tno Toepassing van terpenoide verbindingen in de land- of tuinbouw alsmede voor de bereiding van preparaten voor het bestrijden van witte vliegsoorten.
US5314693A (en) 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
JPH07215846A (ja) * 1994-01-28 1995-08-15 Takeda Chem Ind Ltd 抗アレルギー剤
CA2342403A1 (en) 2001-03-28 2002-09-28 Jean Legault Sesquiterpene derivatives as anticancer agents
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
CA2356438A1 (en) * 2001-09-05 2003-03-05 Andre Pichette Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
WO2004066912A2 (en) * 2003-01-31 2004-08-12 Technion Research & Development Foundation Ltd. Anti-inflammatory compositions and uses thereof
JP2005206520A (ja) * 2004-01-22 2005-08-04 Univ Kinki アテローム性動脈硬化抑制剤ならびにこれを含む食品および医薬

Also Published As

Publication number Publication date
JP2008514649A (ja) 2008-05-08
ATE518531T1 (de) 2011-08-15
BRPI0419105B8 (pt) 2021-05-25
EP1809268B1 (en) 2011-08-03
CA2577219A1 (en) 2006-04-13
MX2007002116A (es) 2007-10-16
US20080280996A1 (en) 2008-11-13
EP1809268A1 (en) 2007-07-25
WO2006037194A1 (en) 2006-04-13
BR122016029094B1 (pt) 2021-10-13
AR048806A1 (es) 2006-05-31
BRPI0419105B1 (pt) 2006-04-13

Similar Documents

Publication Publication Date Title
DK1420801T3 (da) Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
BRPI0419105A (pt) usos de cariofilenos ou composições que compreendem cariofilenos, método de tratamento de condições inflamatórias e dores inflamatórias, método de inibição e composição que compreende cariofileno
WO2006024018A3 (en) Compositions for treating nociceptive pain
WO2008063213A3 (en) Uses and compositions for treatment of psoriatic arthritis
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
WO2007092622A3 (en) Compositions and methods for treating bone
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA201001865A1 (ru) Противовоспалительные агенты
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
TNSN08400A1 (en) Organic compounds and their uses
DK1758860T3 (da) Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande
WO2007005720A3 (en) Methods and compositions for promoting wound healing
TW200716088A (en) Formulations and methods for treating amyloidosis
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
BRPI0603772A (pt) composições para a inibição ou redução de inflamação da pele
DK1429756T3 (da) Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
MX2007010484A (es) Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2.
DK1648484T3 (da) Fremgangsmåde til behandling af arthritis-tilstande
BRPI0517966A (pt) composição contra demodicose
BRPI0610722A2 (pt) métodos para tratar uma infecção bacteriana, para prevenir, tratar ou melhorar o tratamento eficaz de mrsa, para inibir o crescimento de um micróbio, e para selecionar um agente terapêutico de mrsa útil pata tratar uma infcção bacteriana, e, composição
BRPI0711885A2 (pt) Aminotiazóis e seus usos
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2326 DE 04/08/2015.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REF. RPI 2378 DE 02/08/2016, DEVIDO A INCORRECAO NA JUNTADA, EM FORMATO DIGITAL, DOS DOCUMENTOS ENCAMINHADOS PELA ANVISA.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: "INPI NO 52402.007437/2022-69 ORIGEM: 7A VARA CIVEL FEDERAL DE SAO PAULO PROCESSO NO: 5003067-27.2022.4.03.6101 SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: LUIZ FRANCISCO PIANOWSKI REU(S): ACHE LABOTATORIOS FARMACEUTICOS S/A E INSTITUTONACIONAL DA PROPRIEDADE INTELECTUAL"